This opportunity funds pathobiology research to advance understanding of Long COVID. It supports collaborative projects using RECOVER biospecimens and data from observational cohorts, tissue pathology, and clinical trials. Both new and previously funded RECOVER investigators are encouraged to apply. The award uses the Other Transaction Authority mechanism, distinct from traditional NIH grants.
Eligible applicants include investigators from academic, government, non-profit, and other institutions eligible for federal funding. Both new and previously funded RECOVER investigators may apply, including teams proposing research using RECOVER biospecimens and data.
